One of these pathways is that of the mitochondrial, hypoxia-mediated ROS-induced activation of c-Src, HIF-1α, and NF-κB which contributes to cell survival in various cancers including hepatomas, colon carcinomas, and neuroblastomas [20]. Here, SRC is linked to cancer.